Higher FABP3 levels have been observed in the cerebrospinal fluid and serum of patients with Alzheimer’s disease, dementia with Lewy bodies or Parkinson’s disease [11,12]. This evidence concerns the gene FABP3 and early-onset autosomal dominant Alzheimer disease.